Tumor-informed or tumor-agnostic circulating tumor DNA as a biomarker for risk of recurrence in resected colorectal cancer patients

INTRODUCTION: Circulating tumor DNA (ctDNA) has been increasingly recognized as a promising minimally-invasive biomarker that could identify patients with minimal residual disease and a high risk of recurrence after definitive treatment. In this study, we’ve compared the clinical utility and sensiti...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Hiu Ting, Nagayama, Satoshi, Otaki, Masumi, Chin, Yoon Ming, Fukunaga, Yosuke, Ueno, Masashi, Nakamura, Yusuke, Low, Siew-Kee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909342/
https://www.ncbi.nlm.nih.gov/pubmed/36776372
http://dx.doi.org/10.3389/fonc.2022.1055968

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909342/
https://www.ncbi.nlm.nih.gov/pubmed/36776372
http://dx.doi.org/10.3389/fonc.2022.1055968

Ejemplares similares